ArticleOncoimmunology2021
PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity.
Haiping Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this papertrialcites it
ArticleOncoimmunology2021
Haiping Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.